Skip to main content
. 2023 Apr 23;13(8):2605–2615. doi: 10.7150/thno.81760

Figure 1.

Figure 1

Aberrant glycosylation in cancer. A) Overview of general N-glycosylation changes described in cancer. Specific examples of functional consequences of aberrant N-glycosylation are depicted for the B7 family of immune checkpoints and Endothelial Growth Factor Receptor (EGFR) are in panels B and C, respectively. Figure created with BioRender.com.